Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Inhibikase Therapeutics | 435.56 Mn | 276.54 Mn | - | 174.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174.57 Mn |
| Mar 31, 2026 | 172.31 Mn |
| Dec 31, 2025 | 98.31 Mn |
| Sep 30, 2025 | 90.05 Mn |
| Jun 30, 2025 | 90.01 Mn |
| Mar 31, 2025 | 89.54 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 4.19 Mn |